Literature DB >> 15907880

Affibody protein capture microarrays: synthesis and evaluation of random and directed immobilization of affibody molecules.

Björn Renberg1, Ikue Shiroyama, Torun Engfeldt, Per-Ke Nygren, Amelie Eriksson Karlström.   

Abstract

Affibody molecules, 58-amino acid three-helix bundle proteins directed to different targets by combinatorial engineering of staphylococcal protein A, were used as capture ligands on protein microarrays. An evaluation of slide types and immobilization strategies was performed to find suitable conditions for microarray production. Two affibody molecules, Z(Taq) and Z(IgA), binding Taq DNA polymerase and human IgA, respectively, were synthesized by solid phase peptide synthesis using an orthogonal protection scheme, allowing incorporation of selective immobilization handles. The resulting affibody variants were used for random surface immobilization (through amino groups) or oriented surface immobilization (through cysteine or biotin coupled to the side chain of Lys58). Evaluation of the immobilization techniques was carried out using both a real-time surface plasmon resonance biosensor system and a microarray system using fluorescent detection of Cy3-labeled target protein. The results from the biosensor analyses showed that directed immobilization strategies significantly improved the specific binding activity of affibody molecules. However, in the microarray system, random immobilization onto carboxymethyl dextran slides and oriented immobilization onto thiol dextran slides resulted in equally good signal intensities, whereas biotin-mediated immobilization onto streptavidin-coated slides produced slides with lower signal intensities and higher background staining. For the best slides, the limit of detection was 3 pM for IgA and 30 pM for Taq DNA polymerase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907880     DOI: 10.1016/j.ab.2005.03.039

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity.

Authors:  Joel Lindgren; Anna Wahlström; Jens Danielsson; Natalia Markova; Caroline Ekblad; Astrid Gräslund; Lars Abrahmsén; Amelie Eriksson Karlström; Sebastian K T S Wärmländer
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

Review 2.  A new generation of protein display scaffolds for molecular recognition.

Authors:  Ralf J Hosse; Achim Rothe; Barbara E Power
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

3.  Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence.

Authors:  Torun Engfeldt; Anna Orlova; Thuy Tran; Alexander Bruskin; Charles Widström; Amelie Eriksson Karlström; Vladimir Tolmachev
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-05       Impact factor: 9.236

4.  Peptide conformations for a microarray surface-tethered epitope of the tumor suppressor p53.

Authors:  Jun Feng; Ka-Yiu Wong; Gillian C Lynch; Xiaolian Gao; B Montgomery Pettitt
Journal:  J Phys Chem B       Date:  2007-11-16       Impact factor: 2.991

5.  Affibody-Binding Ligands.

Authors:  Annalisa Barozzi; R Ashton Lavoie; Kevin N Day; Raphael Prodromou; Stefano Menegatti
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

Review 6.  Non-antibody protein-based biosensors.

Authors:  Paul Ko Ferrigno
Journal:  Essays Biochem       Date:  2016-06-30       Impact factor: 8.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.